Lista de obras -

'State of the art' of radical hysterectomy; current practice in European oncology centres

artículo científico publicado en 2004

2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth ⬇️

artículo científico publicado el 1 de noviembre de 2003

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

artículo científico publicado en 2005

3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.

artículo científico publicado en 2005

A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer.

artículo científico publicado en 2017

A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer

artículo científico publicado en 2016

A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers

artículo científico publicado en 2017

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

scientific article published on 01 February 2019

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse

artículo científico publicado en 2016

A Systematic Review of Estimating Breast Cancer Recurrence at the Population-Level with Administrative Data

artículo científico publicado en 2020

A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium

artículo científico publicado en 2013

A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.

artículo científico publicado en 2013

A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer

artículo científico publicado en 2005

A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model.

artículo científico publicado en 1999

A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples

artículo científico publicado en 2014

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.

artículo científico publicado en 2010

A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer

artículo científico publicado en 2017

A new prognostic model for FIGO stage 1 epithelial ovarian cancer

artículo científico publicado en 2006

A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study.

artículo científico publicado en 2011

A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling

scientific article published on 19 June 2020

A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer

artículo científico publicado en 2014

A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgery

artículo científico publicado en 2014

A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy

artículo científico publicado en 2011

A phase II study of 5-fluorouracil/cisplatin in recurrent cervical cancer

artículo científico publicado en 1990

A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomas

scientific article published on 01 January 1990

A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study

artículo científico publicado en 2004

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer

scientific article published on 26 October 2012

A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer

artículo científico publicado en 2009

A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer

artículo científico publicado en 2012

A randomized phase III trial in patients with recurrent platinum sensitive ovarian cancer comparing efficacy and safety of paclitaxel micellar and Cremophor EL-paclitaxel

artículo científico publicado en 2019

A randomized trial of adjuvant progestagen in early endometrial cancer

artículo científico publicado en 1989

A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen.

artículo científico publicado en 1998

A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer

artículo científico publicado en 2019

A realistic clinical perspective of tamoxifen and endometrial carcinogenesis

artículo científico publicado en 1996

A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer

artículo científico publicado en 2017

A review of phase II studies of ZD9331 treatment for relapsed or refractory solid tumours ⬇️

artículo científico publicado el 1 de mayo de 2003

A review of the efficacy of anastrozole in postmenopausal women with advanced breast cancer with visceral metastases.

artículo científico publicado en 2003

A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group

artículo científico publicado en 1997

A scoring system to differentiate malignant from benign masses in specific ultrasound-based subgroups of adnexal tumors

scientific article published on 01 January 2009

A thin and regular endometrium on ultrasound is very unlikely in patients with endometrial malignancy

artículo científico publicado en 2007

A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?

artículo científico publicado en 2015

ABCA transporter gene expression and poor outcome in epithelial ovarian cancer

artículo científico publicado en 2014

ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas

scientific article published on August 2013

ABCB1 Variation Affects Myelosuppression, Progression-free Survival and Overall Survival in Paclitaxel/Carboplatin-treated Ovarian Cancer Patients

artículo científico publicado en 2018

AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer

artículo científico publicado en 2016

Absence of correlation between risk factors for endometrial cancer and the presence of tamoxifen-associated endometrial polyps in postmenopausal patients with breast cancer

artículo científico publicado en 2000

Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients

artículo científico publicado en 2004

Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.

artículo científico publicado en 2009

Additional value of PET-CT in staging of clinical stage IIB and III breast cancer.

artículo científico publicado en 2010

Adipose tissue in offspring of Lepr(db/+) mice: early-life environment vs. genotype

scientific article published on 05 September 2006

Adjuvant therapy for early staged (epithelial) cancer

artículo científico publicado en 2004

Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of view

artículo científico publicado en 2006

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

artículo científico

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

artículo científico publicado en 2018

Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel ⬇️

artículo científico publicado el 11 de octubre de 2010

Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer

artículo científico publicado en 2007

Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study

artículo científico publicado en 2015

Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865).

artículo científico publicado en 2006

Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study

artículo científico publicado en 2003

Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortium

artículo científico publicado en 2014

Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci

artículo científico publicado en 2017

Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D

scientific article published on 21 January 2020

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

artículo científico publicado en 2013

Anaplastic nodules in an ovarian mucinous tumor. Case report and literature review

artículo científico publicado en 1998

Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study

artículo científico publicado en 2000

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2014

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

scientific article published on 01 July 2019

Application of proteomics in ovarian cancer: which sample should be used?

artículo científico publicado en 2009

Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers

artículo científico publicado en 2012

Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography?

artículo científico publicado en 2013

Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis

artículo científico publicado en 2011

Aromatase inhibitors in premenopausal women: the need for proper contraceptive counseling

artículo científico publicado en 2006

Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses.

artículo científico publicado en 1999

Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

artículo científico publicado en 2016

Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors

artículo científico publicado en 2020

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

artículo científico publicado en 2016

Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related

artículo científico publicado en 2005

Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer

artículo científico publicado en 2005

Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study

artículo científico publicado en 2016

Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive

artículo científico publicado en 2008

B-cell hybridoma as intraperitoneal tumor model: correlation between tumor growth and monoclonal antibody production

artículo científico publicado en 1992

BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD).

artículo científico publicado en 2014

Balancing false positives and false negatives for the detection of differential expression in malignancies.

artículo científico publicado en 2004

Belgian register and reference centers for gestational trophoblastic diseases

artículo científico publicado en 2015

Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial.

artículo científico publicado en 2015

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial

artículo científico publicado en 2014

Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial

artículo científico publicado en 2017

Bifunctional pathway of uterine carcinosarcomas

scientific article published on 01 March 2003

Bilateral Mammary Tuberculosis Associated with a Borderline Ovarian Tumor ⬇️

artículo científico publicado el 24 de junio de 2008

Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer

artículo científico publicado en 2001

Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

artículo científico publicado en 2020

Body mass index and HER-2 overexpression in breast cancer patients over 50 years of age

artículo científico publicado en 2007

Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study.

artículo científico publicado en 2017

Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers.

artículo científico publicado en 2013

Breast cancer subtype and survival by parity and time since last birth.

artículo científico publicado en 2018

Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study

artículo científico publicado en 2011

CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial

artículo científico publicado en 2012

CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma

artículo científico publicado en 2005

Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes

artículo científico publicado en 2009

Carboplatin and paclitaxel in combination with oral enzastaurin in advanced ovarian or primary peritoneal cancer: results from a safety lead-in study

artículo científico publicado en 2009

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial

artículo científico publicado en 2014

Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study

artículo científico publicado en 2014

Central Pathology Review in SENTIX, A Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2)

scientific article published on 29 April 2020

Cervical carcinoma: optimized local staging with intravaginal contrast-enhanced MR imaging--preliminary results

artículo científico publicado en 1999

Cervical neoplasia during pregnancy: diagnosis, management and prognosis

artículo científico publicado en 2005

Chairperson's introduction: Surgical skills, especially in the upper abdomen, remain pivotal in the treatment of advanced ovarian cancer

artículo científico publicado en 2011

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study)

artículo científico publicado en 2018

Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies

artículo científico publicado en 2015

Chemotherapy for recurrent cervical cancer

artículo científico publicado en 2007

Choriocarcinoma in Situ in a Partial Hydatidiform Mole A: Case Report

scientific article published on 01 August 2016

Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses.

artículo científico publicado en 2016

Chronic tumor necrosis factor-alpha infusion in gravid C57BL6/J mice accelerates adipose tissue development in female offspring

artículo científico publicado en 2006

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium.

artículo científico publicado en 2017

Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

artículo científico publicado en 2015

Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923).

artículo científico publicado en 2003

Classification of radical hysterectomy adopted by the Gynecological Cancer Group of the European Organization for Research and Treatment of Cancer1

artículo científico publicado en 2008

Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial

artículo científico publicado en 2009

Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer

article

Clinical management of uterine sarcomas

artículo científico publicado en 2009

Clinical outcome after CO₂ laser laparoscopic radical excision of endometriosis with colorectal wall invasion combined with laparoscopic segmental bowel resection and reanastomosis

artículo científico publicado en 2011

Clinical outcome after radical excision of moderate-severe endometriosis with or without bowel resection and reanastomosis: a prospective cohort study

artículo científico publicado en 2014

Clinical outcome of ET-743 (Trabectedin; Yondelis) in high-grade uterine sarcomas: report on five patients and a review of the literature

artículo científico publicado en 2009

Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer

artículo científico publicado en 2017

Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma

artículo científico publicado en 2007

Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens

artículo científico publicado en 2005

Clinical trials in recurrent ovarian cancer

scientific article published on May 2011

Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer

artículo científico publicado en 2005

Combined modality adjuvant therapy for high-risk endometrial cancer

scientific article published on 07 July 2016

Combined pelvic and para-aortic is superior to only pelvic lymphadenectomy in intermediate and high-risk endometrial cancer: a systematic review and meta-analysis

artículo científico publicado en 2020

Combining conventional therapy with immunotherapy: A risky business?

scientific article published on 06 April 2019

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

artículo científico publicado en 2015

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

artículo científico publicado en 2015

Common variants at 19p13 are associated with susceptibility to ovarian cancer

artículo científico publicado en 2010

Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer

artículo científico publicado en 2015

Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: An analysis of 163 patients ⬇️

artículo científico publicado el 27 de septiembre de 2010

Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study

artículo científico publicado en 2020

Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy

scientific article published on 22 September 2020

Concordance between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial

artículo científico publicado en 2020

Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk

artículo científico publicado en 2014

Controversies regarding tamoxifen and uterine carcinoma

artículo científico publicado en 1998

Corrigendum to "Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer" [Eur J Cancer 53 (2016) 51-64].

artículo científico publicado en 2016

Corrigendum to “Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (p

scholarly article published in European Journal of Cancer

Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers

artículo científico publicado en 2020

Cumulative dosage effect of a RAD51L1/HMGA2 fusion and RAD51L1 loss in a case of pseudo-Meigs' syndrome

scientific article published on 01 December 2001

Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease

scientific article published on 08 December 2020

Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients

artículo científico publicado en 2016

Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium

artículo científico publicado en 2013

D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study

artículo científico publicado en 2001

Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging

artículo científico publicado en 2006

Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial

artículo científico publicado en 2011

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer

artículo científico publicado en 2020

Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

artículo científico publicado en 2011

Dendritic cell immunotherapy in uterine cancer. ⬇️

artículo científico publicado en 2014

Dendritic cell-based immunotherapy in ovarian cancer

artículo científico publicado en 2013

Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models

scientific article published on 17 March 2020

Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.

artículo científico publicado en 2017

Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer.

artículo científico publicado en 2009

Diet-induced obesity in gravid rats engenders early hyperadiposity in the offspring

artículo científico publicado en 2007

Differentiating stage I epithelial ovarian cancer from benign disease in women with adnexal tumors using biomarkers or the ROMA algorithm.

artículo científico publicado en 2013

Diffusely Metastasized Adenocarcinoma Arising in a Mucinous Carcinoid of the Ovary: A Case Report

artículo científico publicado en 2018

Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice

artículo científico publicado en 1992

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?

artículo científico publicado en 2008

Does paclitaxel-carboplatin chemotherapy in a dose-dense regimen enhance survival of BRCA-related ovarian cancer patients?

artículo científico publicado en 2009

Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).

artículo científico publicado en 2016

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

article published in 2003

Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer.

artículo científico publicado en 2018

Dysgerminoma of the ovary in association with XY gonadal dysgenesis

artículo científico publicado en 1983

Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management

artículo científico publicado en 2015

EMR 20006-012: A phase II randomized double-blind placebo controlled trial comparing the combination of pimasertib (MEK inhibitor) with SAR245409 (PI3K inhibitor) to pimasertib alone in patients with previously treated unresectable borderline or low

artículo científico publicado en 2019

ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer

artículo científico publicado en 2016

EORTC-GCG process quality indicators for ovarian cancer surgery

artículo científico publicado en 2008

EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia

artículo científico

ERBB-2 gene overexpression and amplification in uterine sarcomas

artículo científico publicado en 2004

ESGO statement on cervical cancer vaccination

artículo científico publicado en 2007

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

scientific article published on 18 December 2020

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

scientific article published on 02 May 2019

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†

artículo científico publicado en 2019

EXPRESSION III: Patient´s Expectations and Preferences regarding Physician-Patient Relationship and Clinical Management. Results of the International NOGGO/ENGOT-ov4-GCIG study in 1,830 Ovarian Cancer Patients from European countries.

artículo científico publicado en 2018

Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer

scientific article published on 11 August 2011

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12

artículo científico publicado en 2018

Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial

scientific article published on 08 October 2020

Effect of laparoscopic surgery for moderate and severe endometriosis on depression, relationship satisfaction and sexual functioning: comparison of patients with and without bowel resection

artículo científico publicado en 2013

Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancer

artículo científico publicado en 2007

Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer

scientific article published on 27 September 2020

Endocrine Treatment and Prevention of Breast and Gynecological Cancers Vth International Symposium of the Flemish Gynecological Oncology Group, January 26-28, 2006

scientific article published on 01 September 2006

Endocrine treatment and prevention of breast and gynaecological cancers

artículo científico publicado en 2002

Endodermal sinus tumor of the vulva: successfully treated with high-dose chemotherapy

artículo científico publicado en 2004

Endometrial cancer

artículo científico publicado en 2005

Endometrial cancer: predictors of response and preferred endocrine therapy

artículo científico publicado en 2006

Endometrial carcinosarcoma with osteoclast-like giant cells.

artículo científico publicado en 2006

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer

scientific article published on 01 August 2005

Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation ⬇️

artículo científico publicado el 1 de octubre de 2003

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature

artículo científico publicado en 2003

Endometriosis and the development of malignant tumours of the pelvis. A review of literature

artículo científico publicado en 2004

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

artículo científico publicado en 2015

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

artículo científico publicado en 2013

Epithelial ovarian cancer

scientific article published on 01 March 2019

Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatment

artículo científico publicado en 2014

Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

artículo científico publicado en 2015

Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

artículo científico publicado en 2016

Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer

scholarly article published in Nature Genetics

Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels.

artículo científico publicado en 2003

European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies

artículo científico publicado en 2010

European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groupsand industry partners - a new Model D for drug and medical device development

artículo científico publicado en 2020

European Network of Gynaecological Oncological Trial Groups’ Requirements for Trials Between Academic Groups and Industry Partners—First Update 2015

artículo científico publicado en 2015

European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery.

artículo científico publicado en 2016

European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery

scientific article published on 01 September 2017

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

artículo científico publicado en 2017

European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer

scientific article published on 01 January 2020

Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study

artículo científico publicado en 2014

Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre study

scientific article published on 25 June 2018

Evaluation of models to predict lymph node metastasis in endometrial cancer: A multicentre study.

artículo científico publicado en 2016

Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer

artículo científico publicado en 2012

Evaluation of serum CA 125 level as a tumor marker in borderline tumors of the ovary

artículo científico publicado en 1993

Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey

artículo científico publicado en 2020

Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women

article

Evolution in endometrial cancer: evidence from an immunohistochemical study

artículo científico publicado en 2011

Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO).

artículo científico publicado en 2014

Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV)

scientific article published on 05 March 2020

Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OC

artículo científico publicado en 2017

Expression of ERCC1, p53, and class III β-tubulin do not reveal chemoresistance in endometrial cancer: results from an immunohistochemical study.

artículo científico publicado en 2011

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

artículo científico publicado en 2012

Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation

artículo científico publicado en 2008

External validation of mathematical models to distinguish between benign and malignant adnexal tumors: a multicenter study by the International Ovarian Tumor Analysis Group.

artículo científico publicado en 2007

External validation of non-imaging models for predicting distant metastasis in patients with endometrial cancer.

artículo científico publicado en 2016

FIGO Award for Professor Marleen Temmerman

artículo científico publicado en 2009

FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer

artículo científico publicado en 2018

Feasibility of ultrasound-guided percutaneous samplings in the pregnant baboon: a model for studies on transplacental transport

artículo científico publicado en 2008

Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors

artículo científico publicado en 2016

Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer

artículo científico publicado en 2012

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease.

artículo científico publicado en 2016

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

artículo científico publicado en 2012

Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.

artículo científico publicado en 2016

First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG.

artículo científico publicado en 2012

First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin

artículo científico publicado en 2003

Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy.

artículo científico publicado en 2013

Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative study

artículo científico publicado en 2007

Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials

artículo científico publicado en 2004

Fulvestrant versus anastrozole as second-line treatment of advanced breast cancer in postmenopausal women

artículo científico publicado en 2002

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials

artículo científico publicado en 2003

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trials

artículo científico publicado en 2005

Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents

artículo científico publicado en 2005

Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment

artículo científico publicado en 2002

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

artículo científico publicado en 2016

Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers

artículo científico publicado en 2011

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

artículo científico publicado en 2013

Gastrostomy using a "Gastrofix" as an alternative for nasogastric tubes in ovarian cancer surgery

scientific article published on 01 December 1998

Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.

artículo científico publicado en 2006

Gemcitabine-carboplatin-paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients

artículo científico publicado en 2006

Genetic changes in nonepithelial ovarian cancer

artículo científico publicado en 2013

Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer.

artículo científico publicado en 2015

Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer

artículo científico publicado en 2015

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

artículo científico publicado en 2016

Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

artículo científico publicado en 2015

Genome-wide association study identifies a common variant associated with risk of endometrial cancer

artículo científico publicado en 2011

Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.

artículo científico publicado en 2013

Genomic aberrations relate early and advanced stage ovarian cancer

artículo científico publicado en 2012

Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen.

artículo científico publicado en 1998

Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer

artículo científico publicado en 2017

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer

artículo científico publicado en 2016

Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system

artículo científico publicado en 2009

Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting

artículo científico publicado en 2014

Gynecologic cancers in pregnancy: guidelines of an international consensus meeting

scientific article published on May 2009

Gynecologic oncology in pregnancy

artículo científico publicado en 2008

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

artículo científico publicado en 2011

HER-2/neu is an independent prognostic factor in type I endometrial adenocarcinoma.

artículo científico publicado en 2014

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium

artículo científico publicado en 2014

HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?

artículo científico publicado en 2018

HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

artículo científico publicado en 2015

HPV induced ovarian squamous cell carcinoma: case report and review of the literature

artículo científico publicado en 2007

Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1).

artículo científico

Hexamethylmelamine as second-line therapy in platin-resistant ovarian cancer

artículo científico publicado el 1 de diciembre de 1992

High-grade endometrial stromal sarcoma presenting in a 28-year-old woman during pregnancy: a case report

artículo científico publicado en 2010

High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma

artículo científico publicado en 2012

Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer

artículo científico publicado en 2005

Human Chorionic Gonadotropin Regression Curves after Partial or Complete Molar Pregnancy in Flanders: Are They Different from Regression Curves from the Eighties?

artículo científico publicado en 2017

Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma

article published in 2003

Hyperthermic intraperitoneal chemotherapy does not improve survival in advanced ovarian cancer

scientific article published on 01 December 2019

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

artículo científico publicado en 2013

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

artículo científico publicado en 2017

Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer

publication published on 23 June 2021

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

artículo científico publicado en 2015

Images in clinical medicine. Tamoxifen-induced endometrial polyp

scientific article published on 01 November 1996

Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium.

artículo científico publicado en 2018

Immunohistochemical bcl-2 expression, p53 overexpression, PR and ER status in endometrial carcinoma and survival outcomes.

artículo científico publicado en 2008

Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.

artículo científico publicado en 2004

Immunohistochemical determination of hormone receptors in uterine adenosarcomas

artículo científico publicado en 2003

Immunohistochemical expression of CD10 antigen in uterine adenosarcoma

artículo científico publicado en 2004

Immunological parameters as a new lead in the diagnosis of ovarian cancer

artículo científico publicado en 2015

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma.

artículo científico publicado en 2013

Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma

scientific article published on 01 September 2010

Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course

artículo científico publicado en 2015

Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial

article by J Baptist Trimbos et al published 1 January 2003 in Journal of the National Cancer Institute

Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG.

artículo científico publicado en 2013

Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial.

artículo científico publicado en 2014

Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma

artículo científico publicado en 2004

Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies.

artículo científico publicado en 2013

Improving the preoperative classification of adnexal masses as benign or malignant by second-stage tests

artículo científico publicado en 2011

In Early-Stage Breast Cancer, the Estrogen Receptor Interacts With Correlation Between Human Epidermal Growth Factor Receptor 2 Status and Age at Diagnosis, Tumor Grade, and Lymph Node Involvement

artículo científico publicado en 2008

In Vitro Generation of Murine Dendritic Cells for Cancer Immunotherapy: An Optimized Protocol

artículo científico publicado en 2016

In utero exposure to chemotherapy: effect on cardiac and neurologic outcome

artículo científico publicado en 2006

Incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy

artículo científico publicado en 2002

Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors.

artículo científico publicado en 2007

Incorporation of pazopanib in maintenance therapy of ovarian cancer

artículo científico publicado en 2014

Increased Immunosuppression Is Related to Increased Amounts of Ascites and Inferior Prognosis in Ovarian Cancer

scientific article published on 01 November 2019

Increased expression of placental growth factor in high-grade endometrial carcinoma

artículo científico publicado en 2012

Indications, techniques and outcomes for pelvic exenteration in gynecological malignancy

artículo científico publicado en 2014

Ineffective attempt to preserve fertility with a levonorgestrel-releasing intrauterine device in a young woman with endometrioid endometrial carcinoma: a case report and review of the literature.

artículo científico publicado en 2009

Influence of CA125, platelet count and neutrophil to lymphocyte ratio on the immune system of ovarian cancer patients

scientific article published on 09 May 2018

Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

artículo científico publicado en 2016

Integrative kinome profiling identifies mTORC1/2 inhibition as treatment strategy in ovarian clear cell carcinoma.

artículo científico publicado en 2018

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma

artículo científico publicado en 2003

Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer

scientific article published on 10 April 2019

Interval debulking surgery: an alternative for primary surgical debulking?

artículo científico publicado en 2000

Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers

artículo científico publicado en 2015

Intraperitoneal antineoplastic agents in the management of ovarian cancer

artículo científico publicado el 1 de mayo de 1991

Intraperitoneal chemotherapy in ovarian cancer remains experimental

artículo científico publicado en 2006

Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view

scientific article published on 01 April 2008

Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy

artículo científico publicado en 2003

Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group

artículo científico publicado en 2011

Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study.

artículo científico publicado en 2011

Is There a Role for Intraperitoneal Chemotherapy, Including HIPEC, in the Management of Ovarian Cancer?

scientific article published on 12 August 2019

Is it safe to treat endometrial carcinoma endoscopically?

artículo científico publicado en 2009

Is there a role for HIPEC in ovarian cancer?

artículo científico publicado en 2018

Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?

artículo científico publicado en 2006

Joint ENGOT and GOG Foundation requirements for trials with industry partners

scientific article published on 18 July 2019

Joint ENGOT and GOG Foundation requirements for trials with industry partners

artículo científico publicado en 2019

KitGene in Endometrial Carcinoma: An Immunohistochemical and Mutational Analysis ⬇️

artículo científico publicado el 1 de febrero de 2011

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.

artículo científico publicado en 2013

Laparoscopic hysterectomy for early endometrial cancer.

artículo científico publicado en 2010

Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer

artículo científico publicado en 2002

Laparoscopic para-aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2-IIIB.

artículo científico publicado en 2007

Laparoscopic versus robotic-assisted sacrocolpopexy for pelvic organ prolapse: a systematic review

artículo científico publicado en 2016

Laparoscopy in gynaecologic oncology: a review

artículo científico publicado en 1999

Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome

scientific article published on 01 March 2007

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome

artículo científico publicado en 2014

Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer ⬇️

artículo científico publicado el 1 de octubre de 2003

Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study

artículo científico publicado en 2015

Leuven dose-dense paclitaxel/carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma

artículo científico publicado en 2009

Limited clinical benefit from trastuzumab in recurrent endometrial cancer: two case reports.

artículo científico publicado en 2008

Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.

artículo científico publicado en 2005

Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients

artículo científico publicado en 2016

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

artículo científico publicado en 2018

Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer

artículo científico publicado en 2003

Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer.

artículo científico publicado en 2016

Long-term results of weekly paclitaxel carboplatin induction therapy: an effective and well-tolerated treatment in patients with platinum-resistant ovarian cancer

artículo científico publicado en 2012

Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial

artículo científico publicado en 2020

Long-term sexual functioning in women after surgical treatment of cervical cancer stages IA to IB: a prospective controlled study

artículo científico publicado en 2014

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer

article

Lymph node sampling and taking of blind biopsies are important elements of the surgical staging of early ovarian cancer

artículo científico publicado en 2010

Lymphadenectomy in endometrial cancer

artículo científico publicado en 2009

Lymphoedema Functioning, Disability and Health Questionnaire for Lower Limb Lymphoedema (Lymph-ICF-LL): reliability and validity.

artículo científico publicado en 2014

MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

artículo científico publicado en 2020

Management of borderline ovarian neoplasms

artículo científico publicado en 2007

Management of recurrent endometrioid endometrial carcinoma: an overview

artículo científico publicado en 2009

Management of surgical stage III and IV endometrioid endometrial carcinoma: an overview

artículo científico publicado en 2009

Manual lymph drainage may not have a preventive effect on the development of breast cancer-related lymphoedema in the long term: a randomised trial

article

Medical fellowship programme within the Gynaecological Cancer Group of the European Organisation for Research and Treatment of Cancer

artículo científico publicado en 2003

Meigs' syndrome with elevated serum CA 125 levels: two case reports and review of the literature

artículo científico publicado en 1995

Mesonephric (Wolffian) Pseudoendometrioid Carcinoma of the Broad Ligament, Arising From a Papillary Cystadenoma.

artículo científico publicado en 2016

Metastatic breast cancer: sequencing hormonal therapy and positioning of fulvestrant

artículo científico publicado en 2006

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.

artículo científico publicado en 2017

Microsatellite instability in uterine sarcomas

artículo científico publicado en 2001

Microsatellite instable and microsatellite stable primary endometrial carcinoma cells and their subcutaneous and orthotopic xenografts recapitulate the characteristics of the corresponding primary tumor.

artículo científico publicado en 2015

Modulation of CA-125 tumor marker shedding in ovarian cancer cells by erlotinib or cetuximab

artículo científico publicado en 2007

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

artículo científico publicado en 2023

Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium

artículo científico publicado en 2013

Molecular profiling of platinum resistant ovarian cancer: Use of the model in clinical practice

artículo científico publicado en 2006

Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas.

artículo científico publicado en 2016

Morcellation of uterine leiomyomas: a plea for patient triage

scientific article published on 01 November 2015

Morphology and tumor-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survival

artículo científico publicado en 2018

Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinoma

artículo científico publicado en 2013

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.

artículo científico publicado en 2019

Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors

scientific article published on 01 November 2019

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.

artículo científico publicado en 2016

Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.

artículo científico publicado en 2017

Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?

artículo científico publicado en 2009

Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.

artículo científico publicado en 2015

Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature

artículo científico publicado en 2006

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

artículo científico publicado en 2016

Neoadjuvant chemotherapy for ovarian cancer

artículo científico publicado en 2005

Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?

artículo científico publicado en 2012

Neoadjuvant chemotherapy in advanced ovarian cancer: What kind of evidence is needed to convince US gynaecological oncologists? ⬇️

artículo científico publicado el 1 de octubre de 2010

Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancer

scientific article published on 19 September 2011

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

artículo científico publicado en 1998

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

artículo científico publicado en 2010

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

artículo científico publicado en 2018

Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

artículo científico publicado en 2015

New models to predict depth of infiltration in endometrial carcinoma based on transvaginal sonography

artículo científico publicado en 2006

New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genes

artículo científico publicado en 2016

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

artículo científico publicado en 2016

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

artículo científico publicado en 2019

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

artículo científico publicado en 2016

No association between FTO or HHEX and endometrial cancer risk

artículo científico publicado en 2010

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

artículo científico publicado en 2015

Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors

artículo científico

Novel therapies, including enzastaurin, in the treatment of ovarian cancer

artículo científico publicado en 2014

OC04.03: Quantifying the risk of ovarian malignancy prior to surgery based on the IOTA simple rules

Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium

artículo científico publicado en 2015

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

scientific article published on 27 March 2012

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

artículo científico publicado en 2014

Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.

artículo científico

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

scientific article published on 01 December 2019

Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer)

artículo científico publicado en 2019

Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group

artículo científico publicado en 2012

Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study

artículo científico publicado en 2020

Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing.

artículo científico publicado en 2011

Organization and ethical aspects of randomized trials in gynecologic oncology

artículo científico publicado en 2000

Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review

scientific article published on 08 November 2019

Orientation of Preclinical Research in Ovarian Cancer

artículo científico publicado en 2017

Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD.

artículo científico publicado en 2013

Ovarian cancer

artículo científico publicado en 2006

Ovarian cancer and the immune system

scientific article published on 06 January 2017

Ovarian cancer in children and adolescents: A rare disease that needs more attention

artículo científico publicado en 2016

Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group

article

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.

artículo científico

Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer

scientific article published on 10 September 2019

Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group.

artículo científico publicado en 2000

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

artículo científico publicado en 2016

PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer.

artículo científico publicado en 2013

PGF2 alpha levels in breast cancer tissue

scientific article published on 01 November 1984

PTEN mutation analysis in uterine leiomyosarcomas and mixed mullerian sarcomas

artículo científico publicado en 2002

PTEN mutations in uterine sarcomas.

artículo científico publicado en 2002

Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer.

artículo científico publicado en 2018

Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: the PaLiDo study, a phase II nonrandomized multicenter study

artículo científico publicado en 2013

Para-aortic lymph node metastases in locally advanced cervical cancer: Comparison between surgical staging and imaging.

artículo científico publicado en 2015

Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy

artículo científico publicado en 2020

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium

scientific article published on 10 September 2019

Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening

artículo científico publicado en 2019

Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer

scientific article published on 15 August 2019

Patterns of care in surgery for ovarian cancer in Europe

artículo científico publicado en 2010

Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse

artículo científico publicado en 2010

Pelvic exenterations for gynecological malignancies: a study of 36 cases.

artículo científico

Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer

artículo científico publicado en 2006

Performance of the American College of Obstetricians and Gynecologistsʼ Ovarian Tumor Referral Guidelines With a Multivariate Index Assay

artículo científico publicado en 2011

Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy

artículo científico publicado en 2005

Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer

artículo científico publicado en 2009

Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study

scientific article published on 01 December 2000

Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer.

artículo científico publicado en 2001

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group ⬇️

artículo científico publicado el 1 de mayo de 2003

Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer

artículo científico publicado en 2003

Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma

artículo científico

Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group

artículo científico publicado en 2015

Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cance

artículo científico publicado en 2009

Phase II, open-label, randomized, multicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer

scientific article published on 27 December 2011

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

artículo científico publicado en 2008

Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer

artículo científico publicado en 2015

Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer

artículo científico publicado en 2020

Pitfall in the diagnosis of endometrial cancer: case report of an endometrioid adenocarcinoma arising from uterine adenomyosis

artículo científico publicado en 2011

Placental alkaline phosphatase as a tumor marker in ovarian cancer

artículo científico publicado en 1987

Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer--a study by the OVCAD consortium.

artículo científico publicado en 2012

Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients

artículo científico publicado en 2011

Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer

artículo científico publicado en 2016

Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium

artículo científico publicado en 2011

Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma

artículo científico publicado en 2005

Positive DESKTOP and Tian Scores Systems Are Adequate to Predict Optimal (R0) Secondary Debulking Surgery in Ovarian Cancer, But a Negative Score Does Not Preclude Secondary Surgery

artículo científico publicado en 2018

Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer

artículo científico publicado en 2003

Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapy

artículo científico publicado en 2003

Postoperative Evolution of Thickness and Echogenicity of Cutis and Subcutis of Patients With and Without Breast Cancer-Related Lymphedema

scientific article published on 06 February 2014

Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions

artículo científico publicado en 2003

Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors

artículo científico publicado en 2015

Pre-treatment ADC histogram-analysis at whole body diffusion-weighted MRI predicts disease free survival in ovarian cancer.

artículo científico publicado en 2015

Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group

artículo científico publicado en 2016

Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node

artículo científico publicado en 2014

Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) - a study of the TOC Consortium

artículo científico publicado en 2014

Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study

artículo científico publicado en 2012

Preoperative diagnosis of ovarian tumors using Bayesian kernel-based methods

artículo científico publicado en 2007

Preoperative prediction of malignancy of ovarian tumors using least squares support vector machines

artículo científico publicado en 2003

Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing

artículo científico publicado en 2015

Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users.

artículo científico publicado en 2009

Primary invasive mucinous ovarian carcinoma of the intestinal type: importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases.

artículo científico publicado en 2013

Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer

artículo científico publicado en 2011

Primary surgery or neoadjuvant chemotherapy in ovarian cancer: what is the value of comparing apples with oranges?

scientific article published on 01 January 2012

Proceedings of the International Cancer Imaging Society (ICIS) 16th Annual Teaching Course: Glasgow, UK. 3–5 October 2016.

artículo científico publicado en 2016

Progesterone receptor gene variants and risk of endometrial cancer

artículo científico publicado en 2010

Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age related

artículo científico publicado en 2006

Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer

artículo científico publicado en 2018

Prognostic factors in platinum-resistant ovarian carcinoma treated with ifosfamide-etoposide

artículo científico publicado en 2000

Prognostic factors in stage I ovarian carcinoma.

artículo científico publicado en 2001

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium

artículo científico publicado en 2013

Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data.

artículo científico publicado en 2014

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

artículo científico publicado en 2001

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer.

artículo científico publicado en 2011

Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation

artículo científico publicado en 2012

Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data

artículo científico publicado en 2012

Prognostic value of serum HE4 levels and risk of ovarian malignancy algorithm scores at the time of ovarian cancer diagnosis

artículo científico publicado en 2014

Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial

artículo científico publicado en 2014

Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us?

artículo científico publicado en 2007

Prophylactic salpingo-oophorectomy in 51 women with familial breast-ovarian cancer: importance of fallopian tube dysplasia

artículo científico publicado en 2006

Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer

Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data

artículo científico publicado en 2012

Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome

artículo científico publicado en 2008

Prostacyclin, thromboxane and prostaglandin F2 alpha; plasma levels in breast cancer

artículo científico publicado en 1986

Proteomic analysis of laser microdissected ovarian cancer tissue with SELDI-TOF MS.

artículo científico publicado en 2011

Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS.

artículo científico publicado en 2012

Pseudo-Meigs' syndrome caused by a hydropic degenerating uterine leiomyoma with elevated CA 125

artículo científico publicado en 2001

Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case report

scientific article published on 01 October 2006

Psychologic, relational, and sexual functioning in women after surgical treatment of vulvar malignancy: a prospective controlled study

artículo científico publicado en 2014

Psychological impact of endometrial monitoring in tamoxifen-treated postmenopausal breast cancer patients.

artículo científico publicado en 2000

Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis

artículo científico publicado en 2010

Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer--Gynecological Cancer Group (EORTC-GCG).

artículo científico publicado en 2009

Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update

scientific article published on 20 February 2020

Quality of Life Considerations in Gynecologic Cancer

Quality of life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer.

artículo científico publicado en 2018

Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer

artículo científico publicado en 2006

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer.

artículo científico publicado en 2016

Quality of life in patients receiving treatment for gynecologic malignancies: special considerations for patient care

artículo científico publicado en 2003

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy

artículo científico publicado en 2013

Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial

artículo científico publicado en 2010

Radio-immunotargeting in experimental animal models of intraperitoneal cancer

artículo científico publicado el 1 de enero de 1992

Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women

scientific article published on 01 September 2000

Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph node dissection: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG) study in 234 patients

artículo científico publicado en 2007

Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer.

artículo científico

Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer ⬇️

artículo científico publicado el 1 de julio de 2010

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

artículo científico publicado en 2000

Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life

artículo científico publicado en 2015

Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument

artículo científico publicado en 2000

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting

artículo científico publicado en 2017

Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study

artículo científico publicado en 2014

Re: "Comparison of diagnostic usefulness of predictive models in preliminary differentiation of adnexal masses"

artículo científico publicado en 2007

Re: Mol et al. Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models. Gynecol Oncol 2001;80:162-7

scientific article published on 01 October 2001

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).

artículo científico publicado en 2004

Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup

scientific article published on 01 September 2000

Reactive nodular fibrous pseudotumor: case report and review of the literature

artículo científico publicado en 2014

Recurrent copy number alterations in BRCA1-mutated ovarian tumors alter biological pathways.

artículo científico publicado en 2009

Reply to B. Freidlin et al.

artículo científico publicado en 2014

Reply: The performance of the risk of ovarian malignancy algorithm

Report of an early stopped randomized trial comparing cisplatin vs. cisplatin/ifosfamide/ 5-fluorouracil in recurrent cervical cancer

artículo científico publicado en 2004

Report of an unusual problematic uterine smooth muscle neoplasm, emphasizing the prognostic importance of coagulative tumor cell necrosis.

artículo científico publicado en 2005

Reporting on the results of cancer treatment in patients with metastatic liver disease: proposal of symmetric size-dependent CT-criteria for response

artículo científico publicado en 1996

Reproducibility of Lymphoscintigraphic Evaluation of the Upper Limb

artículo científico publicado en 2014

Retrospective Analysis of Outcome of Patients with Metastatic Leiomyosarcoma in a Tertiary Referral Center.

artículo científico publicado en 2018

Rhabdomyosarcoma of the corpus of the uterus: a case report

scientific article published on 01 January 2000

Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study

scientific article published on 05 February 2019

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10

artículo científico publicado en 2013

Roadmap for the European Network of Gynaecological Trial groups (ENGOT) Trials

artículo científico publicado en 2013

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

artículo científico publicado en 2015

Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort

artículo científico publicado en 2020

Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: first report on the technique used in 5 patients.

artículo científico publicado en 2008

Role of IGF-I in Primary Ovarian Cancer - A Study of the OVCAD European Consortium.

artículo científico publicado en 2016

Role of Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer

scientific article published on 12 August 2019

Role of Neoadjuvant Chemotherapy in the Management of Stage IIIC–IV Ovarian Cancer: Survey Results from the Members of the European Society of Gynecological Oncology

artículo científico publicado en 2012

Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium

artículo científico publicado en 2012

Role of adnexectomy in the surgical treatment of cervical adenocarcinoma.

artículo científico publicado en 2005

Role of cyclin-dependent kinase p27 in uterine carcinosarcomas

artículo científico publicado en 2005

Role of diaphragmatic surgery in 69 patients with ovarian carcinoma

scientific article published on 01 March 2008

Role of diaphragmatic surgery in 69 patients with ovarian carcinoma

scientific article published on 01 April 2009

Role of lymphadenectomy and pelvic radiotherapy in patients with clinical FIGO stage I endometrial adenocarcinoma: An analysis of 208 patients

artículo científico publicado en 2006

Role of surgery in ovarian cancer: an update

artículo científico publicado en 2004

Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer

artículo científico publicado en 2018

Safety and dose modification for patients receiving niraparib

artículo científico publicado en 2018

Safety and dose modification for patients receiving niraparib

scientific article published on 01 May 2019

Screening for ovarian carcinoma: not quite there yet

artículo científico publicado en 2009

Second case of uterine mesonephric adenocarcinoma

artículo científico publicado en 2006

Second-line lenvatinib in patients with recurrent endometrial cancer

scientific article published on 17 January 2020

Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial

artículo científico publicado en 2020

Sentinel node dissection is safe in the treatment of early-stage vulvar cancer

artículo científico publicado en 2008

Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I.

artículo científico publicado en 2015

Sexual and psychological functioning in women after pelvic surgery for gynaecological cancer.

artículo científico publicado en 2009

Sexual functioning in women after surgical treatment for endometrial cancer: a prospective controlled study

artículo científico publicado en 2014

Sexual, psychological, and relational functioning in women after surgical treatment for vulvar malignancy: a literature review

artículo científico publicado en 2011

Shared genetics underlying epidemiological association between endometriosis and ovarian cancer

artículo científico publicado en 2015

Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors

artículo científico publicado en 2008

Should tamoxifen users be screened for endometrial lesions?

artículo científico publicado en 1998

Should we screen for endometrial cancer?

artículo científico publicado en 2010

Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women

scientific article published on 01 July 2003

Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group

artículo científico publicado en 2010

Simple ultrasound-based rules for the diagnosis of ovarian cancer.

artículo científico publicado en 2008

Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study

artículo científico publicado en 2010

Size quantification of liver metastases in patients undergoing cancer treatment: reproducibility of one-, two-, and three-dimensional measurements determined with spiral CT.

artículo científico publicado en 1997

Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer.

artículo científico publicado en 2014

Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors

artículo científico publicado en 2017

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2015

Statistical controversies in clinical research: the importance of importance.

artículo científico publicado en 2016

Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up

artículo científico publicado en 2011

Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study.

artículo científico publicado en 2014

Strong vaccine responses during chemotherapy are associated with prolonged cancer survival

scientific article published on 01 March 2020

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.

artículo científico publicado en 2012

Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience.

artículo científico publicado en 1999

Successful conservative treatment of endocervical adenocarcinoma stage Ib1 diagnosed early in pregnancy

scientific article published on 01 January 2008

Supervised classification of array CGH data with HMM-based feature selection

artículo científico publicado en 2009

Surgery during chemotherapy and at relapse of ovarian cancer

artículo científico publicado en 1999

Surgical and systemic management of endometrial cancer: an international survey

artículo científico publicado en 2014

Surgical program building in advanced ovarian cancer: European perspective

artículo científico

Surgical treatment of deeply infiltrating endometriosis with colorectal involvement ⬇️

artículo científico publicado el 13 de enero de 2011

T2-weighted MR imaging of the uterus: comparison of optimized fast spin-echo and HASTE sequences with conventional fast spin-echo sequences

artículo científico publicado en 1998

Tamoxifen and the uterus

artículo científico publicado en 1998

Tamoxifen metabolism and efficacy in breast cancer- a prospective multicentre trial

artículo científico publicado en 2018

Tamoxifen, screening and new oestrogen receptor modulators

artículo científico publicado en 2001

Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome.

artículo científico publicado en 2016

Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group.

artículo científico publicado en 2000

The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer.

artículo científico publicado en 2007

The "Leuven" paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective study

artículo científico publicado en 2012

The "definitive" trial of surgical cytoreduction in advanced-stage ovarian cancer

artículo científico publicado en 2013

The 13th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2010).

artículo científico publicado en 2011

The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership

artículo científico publicado en 2015

The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy

artículo científico publicado en 2018

The Feasibility of Open Laparoscopy in Gynecologic–Oncologic Patients ⬇️

artículo científico publicado el 1 de julio de 1997

The LACC Trial and Minimally Invasive Surgery in Cervical Cancer

scientific article published on 11 September 2019

The Role of Adjuvant Chemotherapy in Surgical Stages I-II Serous and Clear Cell Carcinomas and Carcinosarcoma of the Endometrium: A Collaborative Study ⬇️

artículo científico publicado el 1 de febrero de 2011

The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer.

artículo científico publicado en 2016

The addition of 4% oxygen to the CO(2) pneumoperitoneum does not decrease dramatically port site metastases

scientific article published on 01 November 2008

The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns

artículo científico publicado en 2013

The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned

artículo científico publicado en 2004

The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer

artículo científico publicado en 2015

The diagnostic problem of endometrial stromal sarcoma: report on six cases

artículo científico publicado en 2003

The genetic landscape of 87 ovarian germ cell tumors

scientific article published on 28 August 2018

The impact of body mass index on age at breast cancer diagnosis and breast cancer phenotype

artículo científico publicado en 2015

The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells

artículo científico publicado en 2010

The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women

artículo científico publicado en 2004

The management of borderline tumours of the ovary

artículo científico publicado en 2006

The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment

scientific article published on 07 March 2010

The oestrogen receptor and its selective modulators in gynaecological and breast cancer

artículo científico publicado en 2000

The position of neoadjuvant chemotherapy within the treatment of ovarian cancer

artículo científico publicado en 2006

The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancers

artículo científico publicado en 2013

The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study

artículo científico publicado en 2015

The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing

artículo científico publicado en 2011

The role of diaphragmatic surgery during interval debulking after neoadjuvant chemotherapy: an analysis of 74 patients with advanced epithelial ovarian cancer

artículo científico publicado en 2010

The role of interval debulking surgery in ovarian cancer ⬇️

artículo científico publicado el 1 de noviembre de 2003

The role of neoadjuvant chemotherapy versus primary surgery in the management of stage III ovarian cancer.

artículo científico publicado en 2007

The rs1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in postmenopausal women on tamoxifen

scientific article published on 20 November 2013

The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.

artículo científico publicado en 2003

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study

artículo científico publicado en 2013

The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.

artículo científico publicado en 2009

The use of lymph vessel markers to predict endometrial cancer outcome.

artículo científico publicado en 2010

The utility of proteomics in gynecologic cancers

artículo científico publicado en 2011

Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model

artículo científico publicado en 1992

Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients

artículo científico publicado en 2005

Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer

artículo científico publicado en 2006

Timing of debulking surgery in advanced ovarian cancer

artículo científico publicado en 2008

Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer

scientific article published on 03 December 2019

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval

artículo científico publicado en 2010

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6-12 months) subpopulation of OVA-301 phase III randomized trial

artículo científico publicado en 2010

Transition of endometrial stromal sarcoma into high-grade sarcoma.

artículo científico publicado en 2006

Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesis.

artículo científico publicado en 2003

Treatment algorithm in patients with ovarian cancer

scientific article published on 08 October 2020

Treatment modalities in endometrial cancer

artículo científico publicado en 2007

Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposide.

artículo científico

Treatment of patients with early epithelial ovarian cancer ⬇️

artículo científico publicado el 1 de noviembre de 2003

Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium

artículo científico publicado en 2013

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

artículo científico publicado en 2019

Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol.

artículo científico publicado en 2012

Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot study

artículo científico publicado en 2018

Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy

artículo científico publicado en 2019

Tumour characterisation, staging and operability assessment in ovarian carcinoma: whole body diffusion-weighted MRI versus CT.

artículo científico publicado en 2015

Ultrasound features of different histopathological subtypes of borderline ovarian tumors

artículo científico publicado en 2005

Understanding the problem of inadequately staging early ovarian cancer

scientific article published on 13 January 2010

Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas

artículo científico publicado en 2007

Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian Cancer

artículo científico publicado en 2016

Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study

artículo científico publicado en 2018

Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole.

artículo científico publicado en 2011

Uterine carcinosarcoma with melanocytic differentiation

artículo científico publicado en 2001

Uterine rupture due to 15-methylprostaglandin F2 alpha

artículo científico publicado en 1982

Uterine sarcomas in South African black women: a clinicopathologic study with ethnic considerations

artículo científico publicado en 2001

V-Y Bilateral gluteus maximus myocutaneous advancement flap in the reconstruction of large perineal defects after resection of pelvic malignancies

artículo científico publicado en 2008

Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium

artículo científico publicado en 2012

Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study

scientific article published on 30 July 2020

Value of positron emission tomography of the para-aortic lymph nodes in cervical carcinoma stage IB2-IIIB

scientific article published on 03 November 2008

Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

artículo científico publicado en 2018

Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer

artículo científico publicado en 2014

Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium

artículo científico publicado en 2019

Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors

artículo científico publicado en 2015

Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study

artículo científico publicado en 2016

Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study

artículo científico publicado en 2013

Weekly paclitaxel-carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma

artículo científico publicado en 2012

Weekly paclitaxel/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer

artículo científico publicado en 2012

What is the role of dose-dense therapy?

artículo científico publicado en 2005

What is the role of neoadjuvant chemotherapy in advanced endometrial cancer? ⬇️

artículo científico publicado el 6 de septiembre de 2010

Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial

artículo científico publicado en 2013

Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.

artículo científico publicado en 2013

Whole-body diffusion-weighted MRI versus CT for detection, restaging and operability assessment of recurrent ovarian carcinoma

Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study

artículo científico publicado en 2016

Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcoma

artículo científico publicado en 2011

Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial

artículo científico publicado en 2013

Wilms' tumor gene 1 (WT1) in endometrial carcinoma.

artículo científico publicado en 2008

Wilms' tumor gene 1 (WT1) overexpression in neurons in deep endometriosis: a pilot study

scientific article published on 22 August 2008

Wilms' tumor gene 1 immunotherapy in pelvic gynecological malignancies

artículo científico publicado en 2014

Wilms' tumour gene 1 (WT1) positivity in endothelial cells surrounding epithelial uterine tumours.

artículo científico publicado en 2009

ZD9331 in combination with topotecan: phase I and II experience ⬇️

artículo científico publicado el 1 de mayo de 2003

[Epithelial ovarian cancer (advanced stage): consensus conference (1998)]

scientific article published on 01 July 2000

[Prostaglandin F2 alpha, prostacyclin and thromboxane in benign and malignant breast tumors]

scientific article published on 01 January 1987

mRNA Electroporation of Dendritic Cells with WT1, Survivin, and TriMix (a Mixture of caTLR4, CD40L, and CD70).

artículo científico publicado en 2016

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells

artículo científico publicado en 2012

miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients

artículo científico publicado en 2020

miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study

scientific article published on 05 October 2019

rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

artículo científico publicado en 2018

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

artículo científico publicado en 2011

Lista de obras de

'State of the art' of radical hysterectomy; current practice in European oncology centres

2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth ⬇️

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.

A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer.

A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer

A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse

A Systematic Review of Estimating Breast Cancer Recurrence at the Population-Level with Administrative Data

A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium

A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.

A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer

A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model.

A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.

A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer

A new prognostic model for FIGO stage 1 epithelial ovarian cancer

A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study.

A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling

A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer

A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgery

A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy

A phase II study of 5-fluorouracil/cisplatin in recurrent cervical cancer

A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomas

A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer

A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer

A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer

A randomized phase III trial in patients with recurrent platinum sensitive ovarian cancer comparing efficacy and safety of paclitaxel micellar and Cremophor EL-paclitaxel

A randomized trial of adjuvant progestagen in early endometrial cancer

A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen.

A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer

A realistic clinical perspective of tamoxifen and endometrial carcinogenesis

A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer

A review of phase II studies of ZD9331 treatment for relapsed or refractory solid tumours ⬇️

A review of the efficacy of anastrozole in postmenopausal women with advanced breast cancer with visceral metastases.

A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group

A scoring system to differentiate malignant from benign masses in specific ultrasound-based subgroups of adnexal tumors

A thin and regular endometrium on ultrasound is very unlikely in patients with endometrial malignancy

A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?

ABCA transporter gene expression and poor outcome in epithelial ovarian cancer

ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas

ABCB1 Variation Affects Myelosuppression, Progression-free Survival and Overall Survival in Paclitaxel/Carboplatin-treated Ovarian Cancer Patients

AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer

Absence of correlation between risk factors for endometrial cancer and the presence of tamoxifen-associated endometrial polyps in postmenopausal patients with breast cancer

Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients

Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.

Additional value of PET-CT in staging of clinical stage IIB and III breast cancer.

Adipose tissue in offspring of Lepr(db/+) mice: early-life environment vs. genotype

Adjuvant therapy for early staged (epithelial) cancer

Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of view

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel ⬇️

Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer

Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study

Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865).

Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study

Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortium

Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci

Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

Anaplastic nodules in an ovarian mucinous tumor. Case report and literature review

Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

Application of proteomics in ovarian cancer: which sample should be used?

Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers

Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography?

Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis

Aromatase inhibitors in premenopausal women: the need for proper contraceptive counseling

Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses.

Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related

Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer

Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study